Global Veterinary Antimicrobial Susceptibility Testing Market - 2022-2029

Market Overview

The global veterinary antimicrobial susceptibility testing market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Antimicrobial susceptibility testing is a vital tool for veterinarians in selecting the best agent to treat bacterial diseases in animals.

Market Dynamics

The increasing demand for antimicrobial susceptibility testing for various applications is expected to drive the growth of the global veterinary antimicrobial susceptibility testing market.

The increasing demand for antimicrobial susceptibility testing for various applications is expected to drive the market growth

Antimicrobial susceptibility testing is a valuable diagnostic tool for determining the most effective treatment for bacterial infections in veterinary medicine. The Subcommittee on Veterinary Antimicrobial Susceptibility Testing (VAST) of the Clinical Laboratory and Standards Institute (CLSI) has developed specific test methods and interpretive criteria for veterinary pathogens. This knowledge has enabled veterinarians to treat animal diseases more effectively, protecting animal welfare and human food security. Furthermore, the availability of standardized veterinary pathogen test methods has enabled the development of antimicrobial surveillance programs to detect the emergence of resistance among veterinary pathogens. Antimicrobial susceptibility tests are used to determine which antibiotics a specific bacteria or fungus is susceptible to. Most of the time, this testing is used in conjunction with a Gram stain and culture, which are obtained much faster. Antimicrobial susceptibility tests can help doctors decide which drugs to use and how much to give to patients with difficult-to-treat infections. The growing amount of antimicrobials used in food animals is expected to drive market growth. For instance, According to the OECD, the amount of antimicrobials used in food animals will rise from 63,151 tonnes to 105 596 tonnes globally by 2030. 1 kg of beef requires approximately 45mg of antimicrobials. Furthermore, for 1 kg of chicken, 148mg of antimicrobials are used. In that order, China, the United States, Brazil, India, and Germany are the top five antimicrobial consumers. Hence, the demand for antimicrobial susceptibility testing is expected to increase.

Limitations associated with antimicrobial susceptibility testing is expected to hamper the market growth

One of the primary disadvantages of traditional or manual veterinary antimicrobial susceptibility testing methods (such as agar dilution, chromogenic agar method, disc diffusion, and micro-broth dilution) is the time required to obtain results, ranging from 24 to 48 hours. Automated veterinary antimicrobial susceptibility testing systems provide faster results with higher accuracy and fewer opportunities for human error. However, due to their high cost, the adoption of these systems in veterinary laboratories is limited, particularly in developing countries. Furthermore, these systems require costly reagents and consumables and additional costs for trained personnel. This raises the overall cost of the test. One of the primary reasons for low adoption in both developed and developing countries is the high cost of these diagnostic tests. Veterinary diagnostic laboratories do not prefer to invest in expensive systems because the volumes of veterinary samples received for testing are generally small. Most veterinary practices are small with limited budgets. The high cost of these systems is thus a significant market restraint.

COVID-19 Impact Analysis

This pandemic had a very low (negligible) impact on the veterinary antimicrobial susceptibility testing market because there was no correlation between demand for animal antimicrobial susceptibility testing during the lockdown period and the post-lockdown period. This pandemic had a very low (negligible) impact on the veterinary antimicrobial susceptibility testing market. The lockdowns reduced the number of vet visits and diagnostic testing. Hence COVID-19 is expected to drastically reduce the need for antimicrobial susceptibility testing and the demand for related antimicrobial susceptibility testing products (consumables and instruments). COVID-19 is likely to have a negative impact on the veterinary antimicrobial susceptibility testing market. The lockdown reduced the number of vet visits and ASTs performed by 20-25 percent (especially in quarters 1 and 2 of 2020).

Segment Analysis

The automated AST Instruments segment is expected to dominate the market growth in the forecast period

The increased adoption of these instruments, when compared to other methods, can be attributed to the growth. Furthermore, these instruments have reduced turnaround time and identification time, propelling growth. The instruments are equipped with advanced computer software that interprets susceptibility patterns for each organism and produces error-free results. In veterinary laboratories, discs are most commonly used for AST. To determine sensitivity, small discs infused with specific antibiotic concentrations are used. The method is time-consuming, but the process is of high quality. This method is popular because of its low cost and ease of use. The antimicrobial gradient method, intrinsic resistance, and acquired resistance are among the other methods.

The development of an automatic susceptibility testing system includes electronic devices such as a plate reader, a video capture board, and software that automatically measures and interprets susceptibility results from the inhibition zone surrounding the antimicrobial disc. The choice of which AST method to use in clinical laboratories is primarily determined by financial resources, labour efficiency, and the laboratory's workload. Other factors to consider include the cost of equipment and reagents, the ease of performing the technique, the flexibility in drug selection for testing, the manoeuvrability of automated or semi-automated devices, and the integrity of the methodology. Furthermore, with the rise in the incidence and severity of bacterial infections, there has never been a greater need for more rapid and accurate AST methods.

Geographical Analysis

North America region is expected to hold the largest market share in the global veterinary antimicrobial susceptibility testing market

The market in this region is being driven by increased pet adoption, increased use of antibiotics in animals, and the presence of key players. The market is expected to expand as animal healthcare centers and practitioners increase. For instance, according to the AVMA report, the country had 116,091 veterinary practitioners in 2019; however, the number increased to 118,624 practitioners in 2020. The presence of key players in this region is also expected to drive market growth. For instance, Becton, Dickinson, and Company, or BD, is a multinational medical technology company based in the United States. The company manufactures BD BBL Sensi-Disc antimicrobial susceptibility test discs for veterinary laboratory use. These discs are used in mycobacteria susceptibility testing procedures that use plated media.

Competitive Landscape

The global veterinary antimicrobial susceptibility testing market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are BioMerieux SA, Becton, Dickinson and Company, Synbiosis, Thermo Fisher Scientific, Bruker Corporation, Condalab, Liofilchem S.r.l., HiMedia Laboratories, Bio-Rad Laboratories, Hardy Diagnostics

Becton, Dickinson and Company

Overview: Becton, Dickinson and Company is a medical technology company based in the United States that manufactures and sells medical devices, instrument systems, and reagents. In certain geographies, BD also offers consulting and analytics services. The company was founded in 1897.

Product Portfolio: BD BBL Sensi-Disc antimicrobial susceptibility test discs for veterinary laboratory use. These discs are used for semi-quantitative in vitro susceptibility testing of common, rapidly growing, and certain fastidious bacterial pathogens using the agar disc diffusion test procedure.

Key Developments: On 13th February 2020, Becton, Dickinson and Company collaborated with the Fleming Fund to assist low and middle-income countries in dealing with antimicrobial resistance.

Why Purchase the Report?

Visualize the composition of the global veterinary antimicrobial susceptibility testing market segmentation by product and end-user, highlighting the key commercial assets and players.

Identify commercial opportunities in the global veterinary antimicrobial susceptibility testing market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global veterinary antimicrobial susceptibility testing market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global veterinary antimicrobial susceptibility testing market report would provide an access to an approx. 45+market data table, 40+ figures and 185 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Veterinary Antimicrobial Susceptibility Testing Market- By Product

Automated AST Instruments

Disks & Plates

Culture Media

Accessories & Consumables

Global Veterinary Antimicrobial Susceptibility Testing Market- By End-User

Veterinary Reference Lab

Veterinary Research Institutes

Others

Global Veterinary Antimicrobial Susceptibility Testing Market- By Region

North America

Europe

South America

Asia Pacific

Middle East and Africa